In this video, Antonio Anzueto, MD, talks about the findings and clinical impacts of his team's study that compared fluticasone furoate/umeclidinium/vilanterol in a single inhaler with tiotropium among...
He talks about how and why metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on...
Bincy Abraham, MD, director of the Fondren Inflammatory Bowel Disease Program at Houston Methodist Hospital and cochair of the Advances in Inflammatory Bowel Disease regional meetings, welcomes attendees to...